MK-2461 is an ATP-competitive, selective and orally active wild-type and mutant c-Met inhibitor ( IC 50 s: 0.4-2.5 nM). MK-2461 also inhibits Ron (IC 50 of 7 nM) and Flt1 (IC 50 of 10 nM), MK-2461 shows selective for c-MET over other kinases (lC 50 s = 22-7800 nM). MK-2461 can be used for the study of cancer , such as gastric cancer .
Products | Products > Disease Areas > Gastric Cancer | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > c-Met/HGFR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.